Been digging into some undervalued stocks lately and wanted to share what I found. Most people talk about P/E ratios or P/S when picking stocks, but there's another metric that doesn't get enough attention - the price-to-book ratio. It's actually pretty useful if you know what you're looking for.

So basically, P/B ratio compares what you're paying for a stock to its actual book value. The formula is straightforward: market cap divided by equity book value. What makes it interesting is that it helps you spot stocks trading below what they're actually worth on paper.

Here's the thing though - a P/B under 1 can mean the stock is genuinely cheap, or it could be a red flag. Sometimes a low ratio means the company's earning weak returns or even negative p/e ratio situations where earnings are struggling. That's when you need to dig deeper and look at other metrics too.

I screened for stocks meeting specific criteria - P/B lower than industry median, solid Zacks rankings, and reasonable trading volume. Ended up finding five interesting picks that caught my attention.

Ford stands out as a classic value play here. They're one of the world's biggest automakers, and the numbers show a projected 27.4% EPS growth over the next 3-5 years. USANA Health Sciences is another one - nutritional and wellness products company with a Rank #1 rating and 12% projected growth. Strategic Education, which runs Strayer University and some coding bootcamps, is sitting at 15% projected growth.

Then there's Patria Investments, a Latin America-focused private markets firm with 15.76% projected growth, and Concentrix, a tech-enabled business services company. All five have either A or B Value Scores, which matters when you're trying to separate actual value from value traps.

The key insight here is that you can't just look at P/B in isolation. You need to compare within the same industry, check what the P/E actually looks like, and make sure you're not catching a falling knife. Sometimes a low P/B just means the market knows something you don't.

But if you do your homework and combine low P/B with strong growth projections and solid analyst ratings, you might find some genuinely interesting opportunities. That's what I'm seeing with this batch anyway.